1. Home
  2. Labeler Index
  3. Laurus Labs Limited
  4. 42385-921
  5. NDC Package Code: 42385-921-60 Atazanavir

NDC Package 42385-921-60 Atazanavir

Capsule Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
42385-921-60
Package Description:
60 CAPSULE in 1 BOTTLE
Product Code:
42385-921
Proprietary Name:
Atazanavir
Non-Proprietary Name:
Atazanavir
Substance Name:
Atazanavir Sulfate
Usage Information:
This drug is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Atazanavir belongs to a class of drugs known as protease inhibitors. It may be given with certain other medications (such as cobicistat, ritonavir) to increase ("boost") the levels of atazanavir. This helps atazanavir work better. Atazanavir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, do all of the following: (1) continue to take all HIV medications exactly as prescribed by your doctor, (2) always use an effective barrier method (latex or polyurethane condoms/dental dams) during all sexual activity, and (3) do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.
11-Digit NDC Billing Format:
42385092160
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
60 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 402246 - atazanavir sulfate 150 MG Oral Capsule
  • RxCUI: 402246 - atazanavir 150 MG Oral Capsule
  • RxCUI: 402246 - atazanavir 150 MG (as atazanavir sulfate 170.8 MG) Oral Capsule
  • RxCUI: 402247 - atazanavir sulfate 200 MG Oral Capsule
  • RxCUI: 402247 - atazanavir 200 MG Oral Capsule
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Laurus Labs Limited
    Dosage Form:
    Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • ATAZANAVIR SULFATE 200 mg/1
    • Pharmacologic Class(es):
  • Cytochrome P450 2C8 Inhibitors - [MoA] (Mechanism of Action)
  • Cytochrome P450 3A Inhibitors - [MoA] (Mechanism of Action)
  • Cytochrome P450 3A4 Inhibitors - [MoA] (Mechanism of Action)
  • HIV Protease Inhibitors - [MoA] (Mechanism of Action)
  • Protease Inhibitor - [EPC] (Established Pharmacologic Class)
  • UDP Glucuronosyltransferases Inhibitors - [MoA] (Mechanism of Action)
  • UGT1A1 Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA212579
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    04-30-2021
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    42385-921-4810 BLISTER PACK in 1 CARTON / 6 CAPSULE in 1 BLISTER PACK (42385-921-06)

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 42385-921-60?

    The NDC Packaged Code 42385-921-60 is assigned to a package of 60 capsule in 1 bottle of Atazanavir, a human prescription drug labeled by Laurus Labs Limited. The product's dosage form is capsule and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package.

    Is NDC 42385-921 included in the NDC Directory?

    Yes, Atazanavir with product code 42385-921 is active and included in the NDC Directory. The product was first marketed by Laurus Labs Limited on April 30, 2021 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 42385-921-60?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 60.

    What is the 11-digit format for NDC 42385-921-60?

    The 11-digit format is 42385092160. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-242385-921-605-4-242385-0921-60